Response: Quality testing of mifepristone and misoprostol in 11 countries
International Journal of Gynecology & Obstetrics · 2024
DOI: 10.1002/ijgo.15354 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Jason Bower und 7 weiteren Autor:innen. Beteiligte Einrichtung: Independent Consultant, London, UK. Hauptthemen laut MEDLINE: Misoprostol, Abortifacient Agents, Abortion, Induced, Abortifacient Agents, Nonsteroidal. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Independent Consultant, London, UK.
- Concept Foundation, Geneva, Switzerland.
- International Planned Parenthood Federation, London, UK.
Zitieren
APA
Bower, J., Chinery, L., Fleurent, A., Gülmezoglu, A. M., Im-Amornphong, W., Kilfedder, C., Procter, P., & Tomazzini, A. (2024). Response: Quality testing of mifepristone and misoprostol in 11 countries. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15354
Vancouver
Bower J, Chinery L, Fleurent A, Gülmezoglu AM, Im-Amornphong W, Kilfedder C, et al. Response: Quality testing of mifepristone and misoprostol in 11 countries. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15354
BibTeX
@article{Bower2024,
author = {Bower, Jason and Chinery, Lester and Fleurent, Alessandra and Gülmezoglu, A Metin and Im-Amornphong, Wallada and Kilfedder, Catherine and Procter, Petra and Tomazzini, Alessandra},
title = {Response: Quality testing of mifepristone and misoprostol in 11 countries},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
doi = {10.1002/ijgo.15354}
}
EUVIMED